JNJ-28312141 T21330
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
JNJ-28312141 is an orally active CSF1R inhibitor and a FLT3 inhibitor. JNJ-28312141 is a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSF-1-dependent macrophages and osteoclasts contribute to tumor growth a
CAS nr:
885692-52-4
Purity:
98%
Molecular Weight:
460,57
SMILES:
O=C(C1=NC(C#N)=CN1)NC2=CC=C(C3CCN(C(CN(C)C)=O)CC3)C=C2C4=CCCCC4
Formula:
C26H32N6O2
Pathway:
Target:
